» Articles » PMID: 37634993

Uniting to Defeat Steatotic Liver Disease: A Global Mission to Promote Healthy Livers and Healthy Lives

Citing Articles

An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations.

Gracen L, Aikebuse M, Sarraf B, McPhail S, Russell A, OBeirne J Patient Prefer Adherence. 2024; 18:1845-1855.

PMID: 39280346 PMC: 11397175. DOI: 10.2147/PPA.S468705.


The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.

Younossi Z, Alqahtani S, Funuyet-Salas J, Romero-Gomez M, Yilmaz Y, Keklikkiran C JHEP Rep. 2024; 6(7):101066.

PMID: 39022387 PMC: 11252535. DOI: 10.1016/j.jhepr.2024.101066.


GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver.

Zhu J, Ouyang S, Zhang G, Cao Q, Xin R, Yin H Cell Death Differ. 2024; 31(11):1467-1486.

PMID: 39009654 PMC: 11519926. DOI: 10.1038/s41418-024-01343-0.


Envisioning how to advance the MASH field.

Allen A, Younossi Z, Diehl A, Charlton M, Lazarus J Nat Rev Gastroenterol Hepatol. 2024; 21(10):726-738.

PMID: 38834817 DOI: 10.1038/s41575-024-00938-9.


Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease.

Nobes J, Leith D, Handjiev S, Dillon J, Dow E Diagnostics (Basel). 2024; 14(9).

PMID: 38732374 PMC: 11083526. DOI: 10.3390/diagnostics14090960.